688117.SHG Cheng Du Sheng Nuo Biotec Co. Ltd. A

Healthcare Pharmaceuticals Shanghai Stock Exchange
14.92 CNY
Close of Nov 4, 2026
13.99 32.76
Market cap
CNY 3.29B
P/E
15.5x
P/B
2.64x
ROE
19.2%
Dividend yield
1.09%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 688117.SHG undervalued?

Graham number
Price14.92
Graham value11.06
Premium34.9%

688117.SHG trades 34.9% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cheng Du Sheng Nuo Biotec Co. Ltd. A fundamental analysis

No fundamental analysis for Cheng Du Sheng Nuo Biotec Co. Ltd. A yet.

Cheng Du Sheng Nuo Biotec Co. Ltd. A stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cheng Du Sheng Nuo Biotec Co. Ltd. A

ChengDu ShengNuo Biotec Co.,Ltd. engages in the research and development, production, sale, and export of peptide drugs. It provides semaglutide, tirzepatide, retatrutide, cagrilintide, lanreotide, bivalirudin, epitifibatide, liraglutide; icatibant, octreotide, teriparatide, ziconotide, ganirelix, linaclotide, abaloparatide, terlipressin acetate; levosimendane, thymosin alpha, enfuvirtide, somatostatin, thymopentin, carbetocin, atosiban acetate, exenatide; and leuprorelin, d…

Full company profile